Table 1.
General characteristics and clinical parameters of COVID-19 patients and controls.
| General Characteristics | COVID-19 Patients (N 80) | Controls (N 47) | ||||
|---|---|---|---|---|---|---|
| N (%) | Mean ± SD | Range | N (%) | Mean ± SD | Range | |
| Age (years) | 50.6 ± 9.3 | 28–68 | 53.8 ± 12.6 | 31–73 | ||
| BMI (Kg/m2) | 25.8 ± 4.5 | 17.6–52.2 | 24.0 ± 3.3 | 18.1–32.4 | ||
| Gender | ||||||
| Men | 56 (70) | 33 (70) | ||||
| Women | 24 (30) | 14 (30) | ||||
| Smoking habits | ||||||
| Smokers | 25 (31) | 16 (34) | ||||
| Non-smokers | 55 (69) | 31 (66) | ||||
| Alcohol consumption (U/week) b | 2.1 ± 5.5 | 1–7 | 3.6 ± 4.6 | 0–14 | ||
| RBC (mg/dL) a | 4.9 ± 0.5 | 3.5–7.1 | 5.2 ± 0.5 | 4.4–7.6 | ||
| WBC (mg/dL) aa | 6.5 ± 1.3 | 4.1–11.1 | 7.3 ± 1.4 | 5.4–13.9 | ||
| Hb (g/dL) | 13.9 ± 1.2 | 10.8–16.4 | 13.9 ± 0.7 | 12.1–15.8 | ||
| HCT (%) a | 41.5 ± 4.5 | 15.8–48.0 | 42.8 ± 0.2 | 38.7–48.7 | ||
| MCV (fl/cell) a | 86.4 ± 4.8 | 61.1–97.0 | 83.8 ± 5.0 | 63.0–91.0 | ||
| MCHC (pg/dL) a | 29.2 ± 2.3 | 19.3–34.7 | 27.0 ± 1.9 | 18.9–29.1 | ||
| Neutrophils (%) | 55.0 ± 8.4 | 17–72 | 56.6 ± 6.8 | 44–78 | ||
| Lymphocytes (%) | 34.3 ± 8.1 | 16–76 | 32.5 ± 5.4 | 17–44 | ||
| Monocytes (%) | 8.0 ± 1.8 | 2–12 | 7.7 ± 2.1 | 2–14 | ||
| Eosinophils (%) | 2.4 ± 1.6 | 0–8 | 2.4 ± 1.4 | 1–8 | ||
| Basophils (%) | 0.3 ± 0.5 | 0–2 | 0.6 ± 0.6 | 0–2 | ||
| Platelets (mg/dL) a | 239.0 ± 52.2 | 97–398 | 251.3 ± 36.3 | 116–347 | ||
| H2O2 (mg/dL) | 65.4 ± 80.0 | 1.8–465.5 | 59.2 ± 78.7 | 1.5–313.0 | ||
| MDA (µm) a | 4.9 ± 3.5 | 1.2–24.9 | 2.8 ± 0.9 | 1.2–5.1 | ||
RBC: red blood cells; WBC: white blood cells; Hb: hemoglobin; HCT: hematocrit value; MCV: mean corpuscular volume; MCHC: mean corpuscular hemoglobin concentration. a = p ≤ 0.001; b = p ≤ 0.05.